511 related articles for article (PubMed ID: 9472800)
1. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells.
El-Badri NS; Wang BY; Cherry ; Good RA
Exp Hematol; 1998 Feb; 26(2):110-6. PubMed ID: 9472800
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
Shizuru JA; Jerabek L; Edwards CT; Weissman IL
Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
[TBL] [Abstract][Full Text] [Related]
3. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
Gaines BA; Colson YL; Kaufman CL; Ildstad S
Exp Hematol; 1996 Jul; 24(8):902-13. PubMed ID: 8690049
[TBL] [Abstract][Full Text] [Related]
4. Long-term reconstitution of mice after ex vivo expansion of bone marrow cells: differential activity of cultured bone marrow and enriched stem cell populations.
Knobel KM; McNally MA; Berson AE; Rood D; Chen K; Kilinski L; Tran K; Okarma TB; Lebkowski JS
Exp Hematol; 1994 Dec; 22(13):1227-35. PubMed ID: 7957709
[TBL] [Abstract][Full Text] [Related]
5. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
RamÃrez M; Rottman GA; Shultz LD; Civin CI
Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
[TBL] [Abstract][Full Text] [Related]
6. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.
Uchida N; Tsukamoto A; He D; Friera AM; Scollay R; Weissman IL
J Clin Invest; 1998 Mar; 101(5):961-6. PubMed ID: 9486965
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
[TBL] [Abstract][Full Text] [Related]
8. Successful allogeneic bone marrow transplantation (BMT) by injection of bone marrow cells via portal vein: stromal cells as BMT-facilitating cells.
Fan TX; Hisha H; Jin TN; Yu CZ; Lian ZX; Guo SB; Cui YZ; Feng B; Yang GX; Li Q; Ikehara S
Stem Cells; 2001; 19(2):144-50. PubMed ID: 11239169
[TBL] [Abstract][Full Text] [Related]
9. Rac2-deficient hematopoietic stem cells show defective interaction with the hematopoietic microenvironment and long-term engraftment failure.
Jansen M; Yang FC; Cancelas JA; Bailey JR; Williams DA
Stem Cells; 2005 Mar; 23(3):335-46. PubMed ID: 15749928
[TBL] [Abstract][Full Text] [Related]
10. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
Robinson S; van Os R; Sheridan T; Mauch P
Stem Cells; 2000; 18(2):93-101. PubMed ID: 10742381
[TBL] [Abstract][Full Text] [Related]
11. Purified hematopoietic stem cells without facilitating cells can repopulate fully allogeneic recipients across entire major histocompatibility complex transplantation barrier in mice.
Wang By; El-Badri NS; Cherry ; Good RA
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14632-6. PubMed ID: 9405664
[TBL] [Abstract][Full Text] [Related]
12. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
Bhattacharyya S; Cowan MJ
Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
[TBL] [Abstract][Full Text] [Related]
13. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
15. Rapid immune reconstitution and dendritic cell engraftment post-bone marrow transplantation with heterogeneous progenitors and GM-CSF treatment.
Zhao P; Liu W; Cui Y
Exp Hematol; 2006 Jul; 34(7):951-64. PubMed ID: 16797423
[TBL] [Abstract][Full Text] [Related]
16. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
17. Experimental manipulations and marrow-derived factors which affect the outcome of bone marrow transplantation across the H-2 barrier in lethally irradiated mice.
Pierpaoli W; Kellerhals R; Buehler A; Sache E
J Clin Lab Immunol; 1985 Mar; 16(3):115-24. PubMed ID: 3897543
[TBL] [Abstract][Full Text] [Related]
18. Isolation of bone marrow-derived stem cells using density-gradient separation.
Juopperi TA; Schuler W; Yuan X; Collector MI; Dang CV; Sharkis SJ
Exp Hematol; 2007 Feb; 35(2):335-41. PubMed ID: 17258082
[TBL] [Abstract][Full Text] [Related]
19. A comparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse.
Rebel VI; Miller CL; Thornbury GR; Dragowska WH; Eaves CJ; Lansdorp PM
Exp Hematol; 1996 Apr; 24(5):638-48. PubMed ID: 8605969
[TBL] [Abstract][Full Text] [Related]
20. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
